Evaluation of Cost Drivers and Cost-Efficacy of Autologous Hematopoietic Transplant and Chimeric Antigen Receptor T-Cell Therapy in High-Grade B Cell Lymphoma from a Healthcare Firm Perspective
Blood（2022）
关键词
autologous hematopoietic transplant,t-cell lymphoma,cost drivers,cost-efficacy,high-grade
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要